The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
EWS/FLI-1 is a chimeric protein formed by a tumor-specific 11;22 translocation found in both Ewing's sarcoma and primitive neuroectodermal tumor of childhood. EWS/FLI-1 has been shown to be a potent transforming gene, suggesting that it plays an important role in the genesis of these human tumors. We now demonstrate that EWS/FLI-1 has the characteristics of an aberrant transcription factor. Subcellular fractionation experiments localized the EWS/FLI-1 protein to the nucleus of primitive neuroectodermal tumor cells. EWS/FLI-1 specifically bound in vitro an ets-2 consensus sequence similarly to normal FLI-1. When coupled to a GAL4 DNA-binding domain, the amino-terminal EWS/FLI-1 region was a much more potent transcriptional activator than the corresponding amino-terminal domain of FLI-1. Finally, EWS/FLI-1 efficiently transformed NIH 3T3 cells, but FLI-1 did not. These data suggest that EWS/FLI-1, functioning as a transcription factor, leads to a phenotype dramatically different from that of cells expressing FLI-1. EWS/FLI-1 could disrupt normal growth and differentiation either by more efficiently activating FLI-1 target genes or by inappropriately modulating genes normally not responsive to FLI-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The strong transactivation activity in the N terminus of EWS contributes to the function of the resulting oncogenic fusion protein (185).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [185]
Citations
Cites
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 3×
“This polypeptide fragment included EWS amino acid residues 244 to 264 (6) fused to residues 241 to 284 of FLI-1 (30).”
BackgroundMethodde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Kamps, M. P., Murre, C., Sun, X.-H., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90658-2 · Cited by 697
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 662
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Stringer, K. F., Ingles, C. J., & Greenblatt, J. (1990) · Nature · doi:10.1038/345783a0 · Cited by 579
Cited by
Items 101–200 of 562
Åman, P. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0130 · Cited by 117
Miyagawa, Y., Okita, H., Nakaijima, H., Horiuchi, Y., Sato, B., Taguchi, T., Toyoda, M., Katagiri, Y. U., Fujimoto, J., Hata, J.-I., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00740-07 · Cited by 117
Minas, T. Z., Surdez, D., Javaheri, T., Tanaka, M., Howarth, M., Kang, H., Han, J. J., Han, Z., Sax, B., Kream, B. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9388 · Cited by 116
Karnieli, E., Werner, H., Rauscher, F. J., Benjamin, L. E., & LeRoith, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19304 · Cited by 116
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
Martinez-Lage, M., Torres-Ruiz, R., Puig-Serra, P., Moreno-Gaona, P., Martin, M. C., Moya, F. J., Quintana-Bustamante, O., Garcia-Silva, S., Carcaboso, A. M., Petazzi, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18875-x · Cited by 115
Efficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma
Toub, N., Bertrand, J., Tamaddon, A. M., Elhamess, H., Hillaireau, H., Maksimenko, A., Maccario, J., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9901-9 · Cited by 115
Patel, M., Simon, J. M., Iglesia, M. D., Wu, S. B., McFadden, A. W., Lieb, J. D., & Davis, I. J. (2012) · Genome Research · doi:10.1101/gr.125666.111 · Cited by 114
Targeting Intrinsically Disordered Transcription Factors: Changing the Paradigm
Tsafou, K., Tiwari, P. B., Forman-Kay, J. D., Metallo, S. J., & Toretsky, J. A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.008 · Cited by 112
Identification and characterization of FUS/TLS as a new target of ATM
Gardiner, M., Toth, R., Vandermoere, F., Morrice, N. A., & Rouse, J. (2008) · Biochemical Journal · doi:10.1042/bj20081135 · Cited by 111
Sümegi, J., Nishio, J., Nelson, M., Frayer, R. W., Perry, D. A., & Bridge, J. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.201 · Cited by 111
Powers, C. A., Mathur, M., Raaka, B. M., Ron, D., & Samuels, H. H. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0043 · Cited by 110
Buijs, A., Rompaey, L. V., Molijn, A. C., Davis, J. N., Vertegaal, A. C. O., Potter, M. D., Adams, C., van Baal, S., Zwarthoff, E. C., Roussel, M. F., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9281-9293.2000 · Cited by 110
Mobley, B. C., Roulston, D., Shah, G. V., Bijwaard, K. E., & McKeever, P. E. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.02.011 · Cited by 110
Oikawa, T., Yamada, T., Kihara-Negishi, F., Yamamoto, H., Kondoh, N., Hitomi, Y., & Hashimoto, Y. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400534 · Cited by 109
“The Fli-1 gene is rearranged with the EWS gene in the development of human Ewing sarcomas by specific chromosomal translocation.(119) Expression of Fli1 as well as EWS-Fli-1 promotes cell proliferation and inhibits apoptosis.”
BackgroundChansky, H. A., Barahmand-Pour, F., Mei, Q., Kahn‐Farooqi, W., Zielinska‐Kwiatkowska, A., Blackburn, M. L., Chansky, K., Conrad, E. U., Bruckner, J. D., Greenlee, T. K., et al. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.12.008 · Cited by 108
Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
dos Santos, N. R., de Bruijn, D. R., Balemans, M., Janssen, B., Gärtner, F., Lopes, J. M., de Leeuw, B., & van Kessel, A. G. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1549 · Cited by 108
Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides
Toretsky, J. A., Connell, Y., Neckers, L., & BHAT, N. K. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005716926800 · Cited by 107
EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin
Siligan, C., Ban, J., Bachmaier, R., Spahn, L., Kreppel, M., Schaefer, K., Poremba, C., Aryee, D. N. T., & Kovar, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208455 · Cited by 106
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis
Marques, M. R., Simpson, D. R., Ngok, S. P., Nieves, B., Ron, C., Siprashvili, Z., Vaka, D., Breese, M. R., Crompton, B. D., Alexe, G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72124 · Cited by 105
Labelle, Y., Bussières, J., Courjal, F., & Goldring, M. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202675 · Cited by 105
EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice
Torchia, E. C., Boyd, K. L., Rehg, J. E., Qu, C., & Baker, S. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-07 · Cited by 104
A fruitful endeavor: Modeling ALS in the fruit fly
Casci, I., & Pandey, U. B. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.064 · Cited by 103
EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi, A., Higashino, F., Aoyagi, M., Yoshida, K., Itoh, M., Kyo, S., Ohno, T., Taira, T., Ariga, H., Nakajima, K., et al. (2003) · PubMed · Cited by 102
Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity
Jaishankar, S., Zhang, J., Roussel, M. F., & Baker, S. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202940 · Cited by 102
Cillo, A. R., Mukherjee, E., Bailey, N. G., Onkar, S., Daley, J. D., Salgado, C. M., Li, X., Liu, D., Ranganathan, S., Burgess, M. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1471 · Cited by 102
Translocations, cancer and the puzzle of specificity
Barr, F. G. (1998) · Nature Genetics · doi:10.1038/475 · Cited by 101
Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.
Sorensen, P. H., Wu, J., Berean, K. W., Lim, J. F., Donn, W., Frierson, H. F., Reynolds, C. P., López-Terrada, D., & Triche, T. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1038 · Cited by 101
Kinsey, M., Smith, R., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1540 · Cited by 97
Self-citationMendiola, M., Carrillo, J., García, E., Lalli, E., Hernández, T., de Álava, E., Tirode, F., Delattre, O., García‐Miguel, P., López‐Barea, F., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21578 · Cited by 95
Lin, P. P., Pandey, M. K., Jin, F., Xiong, S., Deavers, M., Parant, J. M., & Lozano, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0573 · Cited by 95
A Multifunctional Protein, EWS, Is Essential for Early Brown Fat Lineage Determination
Park, J. H., Kang, H. J., Kang, S. I., Lee, J., Hur, J., Ge, K., Mueller, E., Li, H., Lee, B.-C., & Lee, S. B. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.07.002 · Cited by 95
Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor Growth
Carrillo, J., García-Aragoncillo, E., Azorín, D., Agrá, N., Sastre, A., González‐Mediero, I., García‐Miguel, P., Pestaña, Á., Gallego, S., Segura, D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1762 · Cited by 94
Luo, W., Gangwal, K., Sankar, S., Boucher, K. M., Thomas, D., & Lessnick, S. L. (2009) · Oncogene · doi:10.1038/onc.2009.262 · Cited by 93
“EWS/FLI requires both its strong transcriptional activation domain (derived from EWS) and its ETS-type DNA-binding domain (derived from FLI) for oncogenic function (May et al., 1993a, b).”
BackgroundSelf-citationThe N-terminal domain of human TAFII68 displays transactivation and oncogenic properties
Bertolotti, A., Bell, B., & Tora, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203207 · Cited by 93
Sánchez-García, I., & Rabbitts, T. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.7869 · Cited by 92
Structure–Function Relationships of the PEA3 Group of Ets-Related Transcription Factors
de Launoit, Y., Baert, J.-L., Chotteau, A., Monte, D., Defossez, P.-A., Coutte, L., Pelczar, H., & Leenders, F. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2605 · Cited by 90
Johnson, K. M., Mahler, N., Saund, R. S., Theisen, E. R., Taslim, C., Callender, N. W., Crow, J. C., Miller, K. R., & Lessnick, S. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701872114 · Cited by 90
Self-citationIntegrated exome and RNA sequencing of dedifferentiated liposarcoma
Hirata, M., Asano, N., Katayama, K., Yoshida, A., Tsuda, Y., Sekimizu, M., Mitani, S., Kobayashi, E., Komiyama, M., Fujimoto, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13286-z · Cited by 89
Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors
Ozaki, T., Paulussen, M., Poremba, C., Brinkschmidt, C., Rerin, J., Ahrens, S., Hoffmann, C., Hillmann, A., Wai, D., Schaefer, K., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1178 · Cited by 89
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Related Tumors
Tsokos, M., Alaggio, R., Dehner, L. P., & Dickman, P. S. (2012) · Pediatric and Developmental Pathology · doi:10.2350/11-08-1078-pb.1 · Cited by 88
Tarkkanen, M., Kiuru‐Kuhlefelt, S., BLOMQVIST, C. P., Armengol, G., Böhling, T., Ekfors, T., Virolainen, M. J., Lindholm, P., Monge, O. R., Picci, P., et al. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00031-x · Cited by 87
Exposure on Cell Surface and Extensive Arginine Methylation of Ewing Sarcoma (EWS) Protein
Belyanskaya, L. L., Gehrig, P. M., & Gehring, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011446200 · Cited by 86
Sancéau, J., Poupon, M., Delattre, O., Sastre‐Garau, X., & Wietzerbin, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205881 · Cited by 86
Deloulme, J., Prichard, L. B., Delattre, O., & Storm, D. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27369 · Cited by 85
Toretsky, J. A., Thakar, M., Eskenazi, A. E., & Frantz, C. N. (1999) · PubMed · Cited by 85
Javelaud, D., Wietzerbin, J., Delattre, O., & Besançon, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203246 · Cited by 84
Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis
Palmer, R., Lee, S. B., Wong, J. C., Reynolds, P. A., Zhang, H., Truong, V. B., Oliner, J. D., Gerald, W. L., & Haber, D. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00205-2 · Cited by 83
Chaturvedi, A. P., Hoffman, L. M., Jensen, C. C., Lin, Y.-C., Grossmann, A. H., Randall, R. L., Lessnick, S. L., Welm, A. L., & Beckerle, M. C. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-01-0007 · Cited by 78
Self-citationEliazer, S., Spencer, J. A., Ye, D., Olson, E. N., & Ilaria, R. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.482-492.2003 · Cited by 78
Sechler, M., Parrish, J. K., Birks, D. K., & Jedlicka, P. (2017) · Oncogene · doi:10.1038/onc.2017.44 · Cited by 74
Boro, A., Prêtre, K., Rechfeld, F., Thalhammer, V., Oesch, S., Wachtel, M., Schäfer, B. W., & Niggli, F. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.27472 · Cited by 74
CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs
Okimoto, R. A., Wu, W., Nanjo, S., Olivas, V. R., Lin, Y. K., Ponce, R. K., Oyama, R., Kondo, T., & Bivona, T. G. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126366 · Cited by 74
Bertuzzi, A. F., Castagna, L., Nozza, A., Quagliuolo, V., Siracusano, L., Balzarotti, M., Compasso, S., Alloisio, M., Parra, H. J. S., & Santoro, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.033 · Cited by 74
DNA Binding Domain-independent Pathways Are Involved in EWS/FLI1-mediated Oncogenesis
Welford, S. M., Hebert, S. P., Deneen, B., Arvand, A., & Denny, C. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106757200 · Cited by 73
Self-citationMarchetto, A., Ohmura, S., Orth, M. F., Knott, M. M. L., Colombo, M. V., Arrigoni, C., Bardinet, V., Saucier, D., Wehweck, F. S., Li, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16244-2 · Cited by 73
Tirado, Ò. M., Mateo‐Lozano, S., & Notario, V. (2005) · Oncogene · doi:10.1038/sj.onc.1208471 · Cited by 73
Mesenchymal Tumors with EWSR1 Gene Rearrangements
Thway, K., & Fisher, C. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2018.10.007 · Cited by 73
The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells
Amsellem, V., Kryszke, M.-H., Hervy, M., Subra, F., Athman, R., Leh, H., Brachet‐Ducos, C., & Auclair, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.035 · Cited by 72
Expression of EWS-ETS Fusions in NIH3T3 Cells Reveals Significant Differences to Ewing’s Sarcoma
Braunreiter, C. L., Hancock, J. D., Coffin, C. M., Boucher, K. M., & Lessnick, S. L. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3505 · Cited by 71
Self-citationDiagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours
Dockhorn‐Dworniczak, B., Schäfer, K.-L., Dantcheva, R., Blasius, S., Böcker, W., Burdach, S. E. G., Strehl, S., Winkelmann, W., van Valen, F., & Jürgens, H. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00230345 · Cited by 71
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Theisen, E. R., Pishas, K. I., Saund, R. S., & Lessnick, S. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7124 · Cited by 70
Self-citationmiR-708-5p: a microRNA with emerging roles in cancer
Monteleone, N. J., & Lutz, C. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19772 · Cited by 70
SPOP and OTUD7A Control EWS–FLI1 Protein Stability to Govern Ewing Sarcoma Growth
Su, S., Chen, J., Jiang, Y., Wang, Y., Vital, T., Zhang, J., Laggner, C., Nguyen, K. T., Zhu, Z., Prevatte, A. W., et al. (2021) · Advanced Science · doi:10.1002/advs.202004846 · Cited by 70
Molecular genetics of chromosome translocations involvingEWSand related family members
Kim, J., & Pelletier, J. (1999) · Physiological Genomics · doi:10.1152/physiolgenomics.1999.1.3.127 · Cited by 70
Identification of a DNA-binding site and transcriptional target for the EWS–WT1(+KTS) oncoprotein
Reynolds, P. A., Smolen, G. A., Palmer, R., Sgroi, D. C., Yajnik, V., Gerald, W. L., & Haber, D. A. (2003) · Genes & Development · doi:10.1101/gad.1110703 · Cited by 69
Immanuel, D., Zinszner, H., & Ron, D. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4562 · Cited by 69
Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?
Pfeifer, J. D., Hill, D. A., O’Sullivan, M. J., & Dehner, L. P. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.01107.x · Cited by 69
Bojović, B. B., & Hassell, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005509200 · Cited by 68
Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma
Gangwal, K., Close, D., Enriquez, C. A., Hill, C. P., & Lessnick, S. L. (2010) · Genes & Cancer · doi:10.1177/1947601910361495 · Cited by 67
“EWS is an RNA-binding protein of uncertain normal function, while FLI is an ETS family member normally involved in hematopoietic development.18,19 Wild-type FLI contains a weak transcriptional activation domain in its amino terminus and an ETS-type DNA-binding domain and a second transcriptional activation domain in i…”
InfluentialSelf-citationEwing Tumor: Tumor Biology and Clinical Applications
de Álava, E., & Pardo, J. (2001) · International Journal of Surgical Pathology · doi:10.1177/106689690100900104 · Cited by 67
Tel induces a G1 arrest and suppresses Ras-induced transformation
Rompaey, L. V., Potter, M. D., Adams, C., & Grosveld, G. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203899 · Cited by 66
Oyoshi, T., & Kurokawa, R. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-1 · Cited by 66
Interplay among transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy
Külshammer, E., Mundorf, J., Kilinc, M., Frommolt, P., Wagle, P., & Uhlirova, M. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020719 · Cited by 65
EWS‐FLI‐1 and EWS‐ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor
Ida, K., Kobayashi, S., Taki, T., Hanada, R., Bessho, F., Yamamori, S., Sugimoto, T., Ohki, M., & Hayashi, Y. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630407 · Cited by 64
EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma
Tanner, J. M., Bensard, C., Wei, P., Krah, N. M., Schell, J. C., Gardiner, J. D., Schiffman, J. D., Lessnick, S. L., & Rutter, J. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0182 · Cited by 64
Self-citationCONSEQUENCES OF CHROMOSOMAL ABNORMALITIES IN TUMOR DEVELOPMENT
Sánchez-García, I. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.429 · Cited by 64
NKAP is a novel RS-related protein that interacts with RNA and RNA binding proteins
Burgute, B. D., Peche, V. S., Steckelberg, A., Glöckner, G., Gaßen, B., Gehring, N. H., & Noegel, A. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1311 · Cited by 64
Genomic Approaches That Aid in the Identification of Transcription Factor Target Genes
Kirmizis, A., & Farnham, P. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900803 · Cited by 63
Davidoff, A. M. (2010) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2010.03.007 · Cited by 63
EWS/FLI1 Oncogene Activates Caspase 3 Transcription and Triggers Apoptosis In vivo
Sohn, E. J., Li, K., Reidy, K. T., Beers, L. F., Christensen, B. L., & Lee, S. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1993 · Cited by 62
Crompton, B. D., Carlton, A. L., Thorner, A. R., Christie, A. L., Du, J., Calicchio, M. L., Rivera, M. N., Fleming, M. D., Kohl, N. E., Kung, A. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1944 · Cited by 61
Ewing sarcoma family of tumors
West, D. C. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00008 · Cited by 61
Arvand, A., Welford, S. M., Teitell, M. A., & Denny, C. T. (2001) · PubMed · Cited by 60
Self-citationDenton, N. L., Chen, C., Hutzen, B. J., Currier, M. A., Scott, T., Nartker, B. A., Leddon, J. L., Wang, P.-Y., Srinivas, R., Cassady, K. A., et al. (2018) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2018.10.001 · Cited by 60
Showpnil, I. A., Selich‐Anderson, J., Taslim, C., Boone, M. A., Crow, J. C., Theisen, E. R., & Lessnick, S. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac747 · Cited by 60
Self-citationPierz, K. A., Womer, R. B., & Dormans, J. P. (2001) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-200105000-00028 · Cited by 60
Li, H., Smolen, G. A., Beers, L. F., Li, X., Gerald, W. L., Wang, J., Haber, D. A., & Lee, S. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002353 · Cited by 59
Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines
Zwerner, J. P., & May, W. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205486 · Cited by 59
Self-citationSankar, S., Tanner, J. M., Bell, R. N., Chaturvedi, A. P., Randall, R. L., Beckerle, M. C., & Lessnick, S. L. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00241-13 · Cited by 59
Self-citationTargeting Tumor Specific Translocations in Sarcomas in Pediatric Patients for Immunotherapy
Mackall, C. L., Berzofsky, J. A., & Helman, L. J. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200004000-00005 · Cited by 57
Jacques, C., Lamoureux, F., Baud’huin, M., Calleja, L. R., Quillard, T., Amiaud, J., Tirode, F., Rédiní, F., Bradner, J. E., Heymann, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8214 · Cited by 56
Kedage, V., Selvaraj, N., Nicholas, T. R., Budka, J. A., Plotnik, J. P., Jerde, T. J., & Hollenhorst, P. C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.001 · Cited by 56
Grohar, P. J., Kim, S., Rivera, G. O. R., Sen, N., Haddock, S., Harlow, M. L., Maloney, N., Zhu, J., O’Neill, M. J., Jones, T. L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.063 · Cited by 56
Sun, N., Tran, B. V., Peng, Z., Wang, J., Zhang, C., Yang, P., Zhang, T. X., Widjaja, J., Zhang, R. Y., Xia, W., et al. (2022) · Advanced Science · doi:10.1002/advs.202105853 · Cited by 56
Mangham, D. C., & Athanasou, N. A. (2011) · Clinical Sarcoma Research · doi:10.1186/2045-3329-1-6 · Cited by 55
Cancer Stem Cells in Pediatric Sarcomas
Dela Cruz, F. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00168 · Cited by 55
Robinson, L., Panayiotakis, A., Papas, T. S., Kola, I., & Seth, A. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7170 · Cited by 55
Silvany, R. E., Eliazer, S., Wolff, N. C., & Ilaria, R. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203811 · Cited by 55
Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
Brown, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189667 · Cited by 55
2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014)
Leoni, A., Locatelli, A., Morigi, R., & Rambaldi, M. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118059 · Cited by 55
Metadata
- Authors
- May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-12
- Volume
- 13
- Issue
- 12
- Pages
- 7393-7398
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364810
- OpenAlex
- W1789215739
- Cited by
- 497
- References
- 33
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 13 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 8 · 2016: 16 · 2015: 15 · 2014: 22 · 2013: 25 · 2012: 20
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- National Institute of General Medical Sciences (T32GM008042)
- National Institute of Allergy and Infectious Diseases (T32AI007126)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- FLI1, Ewing sarcoma, primitive neuroectodermal tumor, 22 translocation, transcriptional activator, GAL4 DNA-binding domain, nuclear localization
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Molecular Sequence Data, Oncogenes, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Sarcoma, Ewing, Translocation, Genetic, Trans-Activators, 3T3 Cells, Mice, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.